Company / Interest Expense per Share
Apellis Pharmaceuticals, Inc. Interest Expense per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.06
FY2022
5-year range
$0.06 / $0.16
FY2020-FY2022
Trend
-63.0%
vs FY2021
Sector context
#32 of 43
Health Care
What the data says
At $0.06, Apellis Pharmaceuticals, Inc.'s interest expense per share ranks #12 of 43 in the Health Care sector. Increased from $0.06 to $0.06 over the past 2 years.
Based on SEC 10-K filings.
0.06 in FY2022.
Increased from $0.06 to $0.06 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#12 of 43 in Health CareTop 26% of 43This company $0.06 Sector average $18.61
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2022, interest expense per share decreased 63.0% year-over-year.
- Ranks #32 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.06 | -63.0% |
| FY2021 | $0.16 | +182.5% |
| FY2020 | $0.06 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026